)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Sudarshan Pharma Industries
Sudarshan Pharma Industries (543828) investor relations material
Sudarshan Pharma Industries Investor presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Investor presentation summary14 Aug, 2026
Acquisition overview
Proposed acquisition of a USFDA-approved manufacturing unit specializing in APIs and intermediates.
Facility is 40 km from Visakhapatnam Airport, spread over 14 acres, and does not manufacture steroids, penicillin, beta-lactam antibiotics, hormones, or cytotoxic products.
Site benefits from robust infrastructure, including water supply, effluent treatment, and hazardous waste management.
Facility and operations
Four manufacturing blocks and a solvent recovery plant with a total capacity of 584 KL; all blocks are multi-product facilities.
24/7 operations with 200 employees across production, quality, R&D, engineering, and support functions.
Comprehensive material management with segregated storage for raw materials, packaging, finished goods, and hazardous materials.
Utilities include 33 KVA power, backup generators, advanced cooling, steam, compressed air, and water systems.
Quality and compliance
Holds GMP, ISO 9001:2015, ISO 14001:2015, and ISO 45001:2018 certifications.
Approved by USFDA (ANDA-217608), WHO Geneva, and ANVISA.
Quality policy emphasizes international standards, customer satisfaction, and cost-effective operations.
Quality control complies with 21 CFR Part 11, including computer system validation, audit trails, and disaster recovery.
Stability studies conducted per ICH guidelines, with chambers for accelerated and long-term conditions.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Sudarshan Pharma Industries
- Year-over-year profit and revenue growth, cost rationalization, FCCB funding, and US expansion.543828
Q1 26/27 - Strong revenue and profit growth, strategic expansion, and renewed FCCB fundraising drive.543828Q4 25/26
- Strong revenue and profit growth, international expansion, and major fundraising initiatives.543828Q3 25/26
- Revenue, assets, and international presence expanded, with major fundraising and acquisitions approved.543828Q2 2026
- Q1 FY26 delivered strong revenue growth and a return to profit, aided by strategic acquisitions.543828Q1 25/26
- Slight profit dip, major expansion moves, and a significant litigation win mark H1 FY25.543828Q2 24/25
- FY25 saw robust growth, acquisitions, and exceptional items impact at Sudarshan Pharma.543828Q4 24/25
Next Sudarshan Pharma Industries earnings date
Q2 202730 Oct, 2026
Sudarshan Pharma Industries
Next Sudarshan Pharma Industries earnings date
Q2 202730 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage